Action Therapeutics
Semiconductor ManufacturingCalifornia, United States11-50 Employees
Pelvic pain las vegas Henderson incontinence pregnancy post partum tisdale McGinn Action therapeutics.
Expanding Market Presence Action Therapeutics recently went public with an IPO, indicating growing visibility and investor interest, which may facilitate new partnerships and funding opportunities for technology expansion.
Niche Focus Opportunity Specializing in pelvic health and incontinence therapies positions Action Therapeutics in a specialized healthcare segment, offering potential collaboration with physical therapy providers focused on pelvic health.
Emerging Tech Adoption As a semiconductor manufacturing company with a focus on medical applications, there is potential for developing advanced sensor and diagnostic technologies to enhance pelvic health treatments.
Competitive Landscape While operating in a competitive market with large physical therapy chains, targeting small to mid-sized clinics may provide tailored sales opportunities for innovative semiconductor solutions.
Industry Trends Alignment With increasing healthcare emphasis on minimally invasive and tech-enabled treatments, Action Therapeutics can position its products to meet the rising demand for advanced medical devices in pelvic health care.
Action Therapeutics uses 8 technology products and services including Open Graph, oEmbed, GSAP, and more. Explore Action Therapeutics's tech stack below.
| Action Therapeutics Email Formats | Percentage |
| First@actiontherapeuticspt.com | 50% |
| First@actiontherapeuticspt.com | 50% |
Semiconductor ManufacturingCalifornia, United States11-50 Employees
Pelvic pain las vegas Henderson incontinence pregnancy post partum tisdale McGinn Action therapeutics.
Action Therapeutics's revenue is estimated to be in the range of $1M
Action Therapeutics's revenue is estimated to be in the range of $1M